On October 20, 2017, the VCBeat Member Alliance Beijing Alumni Chapter’s visit to the renowned enterprise Novogene was successfully held at Novogene’s R&D headquarters in Tianjin.

VCBeat Members’ Visit to Leading Enterprises: A Tour of Novogene
>>>>Company Visit Profiles
Novogene Co., Ltd. was established in March 2011, focusing on pioneering the application of cutting-edge molecular biology techniques and high-performance computing in life sciences research and human health, with a commitment to becoming a global leader in genomics products and services. Headquartered in Beijing, the company operates laboratories or experimental bases in Tianjin, Nanjing, the United States, and Singapore, and has subsidiaries in Hong Kong, the United States, and the United Kingdom, with office space exceeding 26,000 square meters.
Novogene has become the world’s largest sequencing service center, with an ultra-high-throughput capacity to perform whole-genome sequencing for 200,000 individuals annually. Its globally leading high-performance computing platform and data center capabilities effectively support the big data analysis and storage demands in the fields of life sciences research and healthcare.
Highlights from the Venue
This visit to Novogene marked the first stop in VCBeat’s exclusive “Elite Enterprise Tour” series for its premium members, representing an in-depth exchange focused on precision medicine and genomics. The event was conducted as a roundtable discussion, during which Hu Jintao, Manager of the Genetics Division, shared his valuable expertise, addressed various questions raised by members, and engaged in profound interactive dialogue with the attendees.

10.20 Visit to Renowned Enterprise Novogene: Exchange Meeting Highlights

Roundtable Highlights ()
Summary of Manager Hu Jintao's Sharing:
1. Countries around the world vary in their investment in and emphasis on genomics, leading to differences in the pace of development of precision genomic medicine: the United StatesIn 2016, a budget of $215 million was allocated to launch the Precision Medicine Initiative; in the United Kingdom, a total of £675 million was invested between 2016 and 2017; China’s “Precision Medicine Initiative” was included as a major national science and technology project in the 13th Five-Year Plan, with the Ministry of Science and Technology planning to invest RMB 60 billion in the field of precision medicine by 2030.
2. Two Chinese Academicians Endorsing Genomic Research: Genetic Testing Is the Foundation for Developing Precision Medicine and a Key Measure for Disease Prevention.
3. Estimated Genetic Market: Disease Screening, Cancer Treatment, and Chronic Disease Management,The total market size for gene therapies related to these three major fields is projected to reach 300 billion yuan by 2020.
4. Global Health Statistics: Chronic Diseases Pose Serious Challenges, Necessitating Greater Emphasis on Chronic Disease Management
5. Current Status of the Health Management Industry and Novogene’s “Precision Health Management Program”
① The Three-Step Framework for Health Management: Information Collection (Genetic, Clinical, and Physical Examination Data) — Information Assessment — Provision of Solutions (Intervention)
② Characteristics of genetic information: replicable and transmissible; detectable and analyzable
③ Genetic Risk Assessment: Cardiovascular and Cerebrovascular Diseases, Tumor Screening (Cancers Associated with Lifestyle Factors)
④ Group-Based Health Management: Customized Services
>>>>Visit to the R&D Center Laboratory of Novogene


Visit to the R&D Center Laboratory of Novogene
This event was planned and organized by the entire class committee of the VCBeat Member Alliance Beijing Alumni Association. The event leaders, photographers, and recorders were Xu Yan (Yuntai Interconnect), Sun Rui (GE Healthcare), and Dai Peng (Beijing Xianqian Technology Co., Ltd.). We extend our sincere gratitude to Manager Hu Jintao and Manager Huang Fengjie from the Genetics Business Division of Novogene for their strong support of this event, as well as to all member friends who registered for this visit. The Member Alliance will continue to organize more high-quality offline exchange events to facilitate in-depth communication and achieve win-win cooperation.
>>>>List of Companies for the Next Inspection (Call for Updates)

Company visits are currently being collected and updated, VCBeat members can scan the followingQR Code,Submit the Companies You Wish to Visit; meanwhile,Those interested in joining the "List of Companies to Be Visited》 may also contact us (WeChat ID: vcbeat_m).
Members, scan the QR code below to participate in the corporate tour event.
![[《企业巡访》 报名表]活动二维码.png](http://cdn.vcbeat.top/upload/image/03/10/12/43/1507779819584393.png)
Member Exclusive Circle Introduction
To foster interaction and bring together “those shaping the future of healthcare,” we aim to transform our followers into members and friends, enabling VCBeat to engage more closely with industry professionals and better facilitate mutual recognition and collaboration within this vast community.In March, we launched the Member Inner Circle, joining forces with these steadfast participants and promoters to drive the growth and development of future healthcare.
Since the launch of our exclusive members’ community six months ago, we have received strong support from many of our members. They have willingly extended a helping hand, working with us to continuously refine features and enhance the user experience. In return, we are committed to delivering more comprehensive and in-depth services, providing tangible assistance to our members, and launching offline networking events that are closely integrated with the industry.
Here, there are many industry luminaries and experts, as well as peers from the sector, all engaging in dialogue and growing together.

For those who are not yet VCBeat members, please scan the QR code below to purchase a membership. By becoming a VCBeat member, you can join our exclusive community and engage in various private events and in-depth discussions with industry peers.
